Takehiro Arai

Abiko, JP 
Abiko, JP 

Overview

Takehiro Arai practices practicing medicine in Abiko, Japan.

Their clinical expertise encompasses Genital Warts, Ulcerative Colitis, Hemorrhagic Proctocolitis, and Colitis.

They are actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 3 clinical trials.

Locations

Abiko, Japan
Other Locations
Japan
Yamagata, Japan
Fukushima, Japan
Chiba, Japan
Takasaki, 3700036, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

21 Total Publications

Effect of a motion-correction algorithm on motion-related image quality in mid-diastolic CCTA using 320-detector row CT.
Effect of a motion-correction algorithm on motion-related image quality in mid-diastolic CCTA using 320-detector row CT.
Journal: Journal of cardiovascular computed tomography
Published: April 30, 2026

Frequently Asked Questions about Takehiro Arai

Is Takehiro Arai a top-rated expert for Genital Warts?

MediFind is an objective health platform that identifies experts based on real-world data. Takehiro Arai is classified as an Experienced expert for Genital Warts, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Takehiro Arai participate in research or clinical trials?

Yes. Takehiro Arai has published 21 articles and abstracts on conditions like Genital Warts. You can view a list of Takehiro Arai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Arai's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile